Work

Final results from randomized phase II trial of preoperative docetaxel (D) and capecitabine (C) given sequentially or concurrently for HER2-negative breast cancers.

Year: 2011

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2011.29.15_suppl.1118

Authors: A. B. Zelnak, S. Harichand-Herdt, T. M. Styblo, M. Rizzo, S. G. A. Gabram, H. L. Bumpers, R. C. Hermann, J. Srinivasiah, F. M. Schnell, R. O'Regan

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2521031874

Cites:

Cited by: 6

Related to: 10